MRNA Latest Headlines

Moderna Starts Phase 1 Trial of mRNA-1469 for Bundibugyo Ebolavirus—No Approved Vaccine Exists for This Strain

Market Chameleon (Wed, 5-Aug 7:15 AM)

Moderna gains approval of first-ever mRNA flu vaccine

at seekingalpha.com (Wed, 5-Aug 11:46 PM)

Moderna Shingles Vaccine Trial Terminated: What It Means for MRNA Investors

at www.tipranks.com (Wed, 5-Aug 12:30 PM)

Moderna (MRNA) Receives a Hold from Barclays

at www.tipranks.com (Wed, 5-Aug 4:48 AM)

Moderna Earnings Call Balances Progress With Cash Strain

at www.tipranks.com (Tue, 4-Aug 8:35 PM)

Moderna rises after starting phase 1 trial of Ebola vaccine

at seekingalpha.com (Tue, 4-Aug 1:38 PM)

J.P. Morgan Remains a Sell on Moderna (MRNA)

at www.tipranks.com (Tue, 4-Aug 10:21 AM)

Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND), Moderna (MRNA) and Stevanato Group (STVN)

at www.tipranks.com (Mon, 3-Aug 8:40 AM)

Bank of America Securities Remains a Sell on Moderna (MRNA)

at www.tipranks.com (Mon, 3-Aug 8:35 AM)

Analysts Offer Insights on Healthcare Companies: Moderna (MRNA), BridgeBio Pharma (BBIO) and Universal Health (UHS)

at www.tipranks.com (Mon, 3-Aug 7:20 AM)

RBC Capital Keeps Their Hold Rating on Moderna (MRNA)

at www.tipranks.com (Mon, 3-Aug 7:18 AM)

Analysts Conflicted on These Healthcare Names: BrightSpring Health Services, Inc. (BTSG), Inventiva (IVA) and Moderna (MRNA)

at www.tipranks.com (Mon, 3-Aug 4:40 AM)

Berenberg Bank Keeps Their Hold Rating on Moderna (MRNA)

at www.tipranks.com (Mon, 3-Aug 2:05 AM)

Moderna Eyes mFLUSIVA Approval as 2026 Outlook Improves with Lower Costs and Key Pipeline Progress

Market Chameleon (Fri, 31-Jul 7:32 AM)

Moderna Launches Phase 1 Trial for mRNA-4200: Aiming to Expand Cancer Immunotherapy with Multi-Antigen Targeting

Market Chameleon (Thu, 16-Jul 7:30 AM)

Moderna Welcomes Former Biogen CFO Michael McDonnell to Board, Signaling Focus on Strategic Growth and Financial Strength

Market Chameleon (Wed, 8-Jul 7:09 AM)

MRNA Iron Condor Can Make 83% in Next 12 Days

Market Chameleon (Wed, 8-Jul 11:54 AM)

Moderna Expands mRNA Platform Potential with T-Cell Engagers, CAR-T Program, and Cancer Prevention Initiatives

Market Chameleon (Thu, 25-Jun 8:36 AM)

Moderna’s Upcoming Science Day Shines Spotlight on R&D Acceleration Through AI and Robotics

Market Chameleon (Wed, 17-Jun 7:30 AM)

mRNA Cancer Immunotherapy Shows Early Promise as Platform Approaches Gain Traction in Biotech

Market Chameleon (Mon, 11-May 11:49 AM)

Moderna’s mRNA-1010 Flu Vaccine Shows Superior Efficacy in Phase 3 Study—Regulatory Filings Underway Across Four Continents

Market Chameleon (Thu, 7-May 7:13 AM)